Luke Sergott
Stock Analyst at Barclays
(3.31)
# 1,023
Out of 5,090 analysts
352
Total ratings
49.24%
Success rate
1.84%
Average return
Main Sectors:
Stocks Rated by Luke Sergott
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintains: Equal-Weight | $145 → $165 | $145.49 | +13.41% | 13 | Nov 25, 2025 | |
| EXAS Exact Sciences | Downgrades: Equal-Weight | $77 → $105 | $101.06 | +3.90% | 9 | Nov 21, 2025 | |
| TWST Twist Bioscience | Maintains: Overweight | $40 → $37 | $32.30 | +14.55% | 19 | Nov 17, 2025 | |
| MTD Mettler-Toledo International | Maintains: Overweight | $1,350 → $1,600 | $1,414.86 | +13.09% | 3 | Nov 10, 2025 | |
| NTRA Natera | Maintains: Overweight | $210 → $230 | $244.55 | -5.95% | 5 | Nov 7, 2025 | |
| CERT Certara | Maintains: Overweight | $16 → $14 | $9.22 | +51.84% | 19 | Nov 7, 2025 | |
| TXG 10x Genomics | Maintains: Overweight | $15 → $17 | $17.77 | -4.33% | 14 | Nov 7, 2025 | |
| FTRE Fortrea Holdings | Maintains: Underweight | $8 → $10 | $14.24 | -29.78% | 13 | Nov 6, 2025 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $195 → $210 | $184.31 | +13.94% | 10 | Nov 6, 2025 | |
| SHC Sotera Health Company | Maintains: Overweight | $19 → $20 | $16.75 | +19.40% | 23 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $40 → $45 | $48.03 | -6.31% | 7 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $95 → $100 | $128.96 | -22.46% | 21 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $70 → $85 | $102.02 | -16.68% | 5 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $15 → $12 | $10.93 | +9.79% | 27 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $160 → $175 | $164.98 | +6.07% | 3 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $100 → $105 | $100.79 | +4.18% | 11 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $275 → $325 | $280.23 | +15.98% | 4 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $425 → $485 | $548.12 | -11.52% | 4 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $190 → $185 | $185.80 | -0.43% | 22 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $585 → $625 | $572.77 | +9.12% | 29 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $225 → $250 | $226.25 | +10.50% | 41 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $185 → $200 | $225.85 | -11.45% | 24 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $55 → $53 | $47.01 | +12.74% | 2 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $90 | $102.52 | -12.21% | 1 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $2 → $1.5 | $2.39 | -37.24% | 5 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $400 → $350 | $394.81 | -11.35% | 18 | Apr 10, 2025 |
Agilent Technologies
Nov 25, 2025
Maintains: Equal-Weight
Price Target: $145 → $165
Current: $145.49
Upside: +13.41%
Exact Sciences
Nov 21, 2025
Downgrades: Equal-Weight
Price Target: $77 → $105
Current: $101.06
Upside: +3.90%
Twist Bioscience
Nov 17, 2025
Maintains: Overweight
Price Target: $40 → $37
Current: $32.30
Upside: +14.55%
Mettler-Toledo International
Nov 10, 2025
Maintains: Overweight
Price Target: $1,350 → $1,600
Current: $1,414.86
Upside: +13.09%
Natera
Nov 7, 2025
Maintains: Overweight
Price Target: $210 → $230
Current: $244.55
Upside: -5.95%
Certara
Nov 7, 2025
Maintains: Overweight
Price Target: $16 → $14
Current: $9.22
Upside: +51.84%
10x Genomics
Nov 7, 2025
Maintains: Overweight
Price Target: $15 → $17
Current: $17.77
Upside: -4.33%
Fortrea Holdings
Nov 6, 2025
Maintains: Underweight
Price Target: $8 → $10
Current: $14.24
Upside: -29.78%
Charles River Laboratories International
Nov 6, 2025
Maintains: Overweight
Price Target: $195 → $210
Current: $184.31
Upside: +13.94%
Sotera Health Company
Nov 5, 2025
Maintains: Overweight
Price Target: $19 → $20
Current: $16.75
Upside: +19.40%
Nov 4, 2025
Maintains: Overweight
Price Target: $40 → $45
Current: $48.03
Upside: -6.31%
Oct 31, 2025
Maintains: Underweight
Price Target: $95 → $100
Current: $128.96
Upside: -22.46%
Oct 30, 2025
Maintains: Overweight
Price Target: $70 → $85
Current: $102.02
Upside: -16.68%
Oct 30, 2025
Downgrades: Equal-Weight
Price Target: $15 → $12
Current: $10.93
Upside: +9.79%
Oct 29, 2025
Maintains: Overweight
Price Target: $160 → $175
Current: $164.98
Upside: +6.07%
Oct 28, 2025
Maintains: Overweight
Price Target: $100 → $105
Current: $100.79
Upside: +4.18%
Oct 27, 2025
Maintains: Equal-Weight
Price Target: $275 → $325
Current: $280.23
Upside: +15.98%
Oct 24, 2025
Maintains: Underweight
Price Target: $425 → $485
Current: $548.12
Upside: -11.52%
Oct 24, 2025
Maintains: Equal-Weight
Price Target: $190 → $185
Current: $185.80
Upside: -0.43%
Oct 23, 2025
Maintains: Overweight
Price Target: $585 → $625
Current: $572.77
Upside: +9.12%
Oct 22, 2025
Maintains: Overweight
Price Target: $225 → $250
Current: $226.25
Upside: +10.50%
Oct 2, 2025
Maintains: Equal-Weight
Price Target: $185 → $200
Current: $225.85
Upside: -11.45%
Oct 2, 2025
Maintains: Overweight
Price Target: $55 → $53
Current: $47.01
Upside: +12.74%
Aug 1, 2025
Initiates: Overweight
Price Target: $90
Current: $102.52
Upside: -12.21%
Jun 25, 2025
Maintains: Equal-Weight
Price Target: $2 → $1.5
Current: $2.39
Upside: -37.24%
Apr 10, 2025
Maintains: Equal-Weight
Price Target: $400 → $350
Current: $394.81
Upside: -11.35%